
FONAR Corporation FONR
$ 14.86
-0.03%
Quarterly report 2025-Q3
added 11-10-2025
FONAR Corporation Interest Expense 2011-2025 | FONR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense FONAR Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 347 K | 249 K | 74.3 K | 98.6 K | -160 K | 28.3 K | -262 K | -702 K | -885 K | -500 K | 479 K | 515 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 515 K | -885 K | -60 K |
Quarterly Interest Expense FONAR Corporation
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 K | -1 K | 1 K | -1 K | 45 K | 10 K | 48 K | 15 K | 12 K | 14 K | -197 K | - | 47 K | 811 K | 858 K | 19 K | 16 K | 22 K | 16 K | 22 K | 19 K | 21 K | -19 K | -21 K | -25 K | -25 K | -25 K | -25 K | -48 K | -43 K | -48 K | -43 K | -77 K | -98 K | -77 K | -98 K | -139 K | -150 K | 139 K | 150 K | 172 K | 204 K | 172 K | 204 K | 237 K | 243 K | 237 K | 243 K | 103 K | 76 K | 103 K | 76 K | 124 K | 107 K | 124 K | 107 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 858 K | -197 K | 66.5 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.86 | -3.26 % | $ 134 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 307.92 | -1.93 % | $ 8.69 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 45.13 | -2.67 % | $ 6.72 K | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 125.1 | 1.48 % | $ 218 B | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 92.34 | 0.64 % | $ 136 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 2.56 | 8.94 % | $ 95.5 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 96.35 | -1.06 % | $ 1.22 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.7 | -3.46 % | $ 408 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 62.79 | -1.82 % | $ 3.41 B | ||
|
Pulmonx Corporation
LUNG
|
256 K | $ 2.53 | 0.86 % | $ 99 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.88 | 0.05 % | $ 709 M | ||
|
Myomo
MYO
|
21.1 K | $ 1.06 | -1.85 % | $ 7.47 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 13.41 | -4.56 % | $ 1.03 B | ||
|
NuVasive
NUVA
|
-21.4 M | - | - | $ 2.07 B | ||
|
Align Technology
ALGN
|
7.68 M | $ 165.15 | 0.78 % | $ 12.4 B | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 1.07 | -3.18 % | $ 110 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 12.81 | -1.23 % | $ 346 M | ||
|
Orthofix Medical
OFIX
|
-9.62 M | $ 15.51 | -1.27 % | $ 591 M | ||
|
AxoGen
AXGN
|
-199 K | $ 30.33 | 1.15 % | $ 1.34 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.78 | 2.33 % | $ 1.26 B | ||
|
LENSAR
LNSR
|
660 K | $ 11.48 | -0.17 % | $ 132 M |